Stay updated on DESTINY-B12 Clinical Trial
Sign up to get notified when there's something new on the DESTINY-B12 Clinical Trial page.

Latest updates to the DESTINY-B12 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study descriptions and eligibility criteria for a clinical trial on Trastuzumab deruxtecan, while adding new identifiers and collaborators related to breast cancer research.SummaryDifference24%
- Check30 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.2. The estimated last update posted has been removed.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact for assistance. Additionally, the phrase 'Results Submitted' has been added, while 'No Results Posted' has been removed.SummaryDifference0.9%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to DESTINY-B12 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DESTINY-B12 Clinical Trial page.